Mutant nucleophosmin and cooperating pathways drive leukemia initiation and progression in mice
George S. Vassiliou(Wellcome/MRC Cambridge Stem Cell Institute), Allan Bradley(Granta Design (United Kingdom)), Carolyn Grove(The University of Western Australia), Penny Wright(Canterbury Health Laboratories), Peter Ellis(Oldham Council), Robert Andrews(Wellcome Sanger Institute), Ruby Banerjee(Wellcome Sanger Institute), Anthony G. Uren(Anthony Nolan), Roland Rad(ING Direct), Wei Wang(The University of Texas MD Anderson Cancer Center), Juan Li(University of Cambridge), Stephen V. Rice(St. Jude Children's Research Hospital), Lena Rad(TUM Klinikum), Pentao Liu(Hong Kong Science and Technology Parks Corporation), Jonathan Cooper(Wellcome Sanger Institute), Mark J. Arends(Edinburgh Cancer Research)
Cited by 230
Related Papers
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
|The Lancet|2005|3.4k
High burden and pervasive positive selection of somatic mutations in normal human skin
|Science|2015|1.8k